Organization

AOA Dx Inc

1 abstract

Abstract
GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of ovarian cancer.
Org: AOA Dx Inc, Lady Davis Institute-Jewish General Hospital, McGill University Health Center, University of Montreal Hospital Centre (CRCHUM), University of Montreal,